FDA Head Faces Grilling Over China’s Heparin
This article was originally published in The Pink Sheet Daily
Executive Summary
Lack of inspections “encouraged” bad drugs, lawmaker tells agency chief.
You may also be interested in...
FDA’s Poor Performance “Invites Catastrophe,” House Investigator Says
Good public health response, poor regulatory oversight mark adulterated heparin episode, Nelson testifies.
FDA’s Poor Performance “Invites Catastrophe,” House Investigator Says
Good public health response, poor regulatory oversight mark adulterated heparin episode, Nelson testifies.
FDA Pinpoints Culprit In Bad Heparin
Over-sulfated chondroitin sulfate named as adverse-events link, but China disagrees.